Pharmacodynamic effects of multiple doses of omapatrilat in healthy subjects.

被引：5
|
作者：
Vesterqvist, O [1 ]
Liao, W [1 ]
Manning, JA [1 ]
Uderman, HD [1 ]
Delaney, CL [1 ]
Swanson, BN [1 ]
机构：
[1] Bristol Myers Squibb PRI, Princeton, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80061-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI61
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF MULTIPLE ORAL DOSES OF CC-220 IN HEALTHY SUBJECTS.
    Thomas, M. E.
    Ye, Y.
    Weiss, D.
    Gaudy, A.
    Chen, N.
    Yang, Z.
    Liu, L.
    Schafer, P. H.
    Mandarino, D.
    Palmisano, M.
    O'Mara, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S22 - S22
  • [42] Pharmacokinetic and Pharmacodynamic Effects of Oral CXA-10, a Nitro Fatty Acid, After Single and Multiple Ascending Doses in Healthy and Obese Subjects
    Garner, Rachel M.
    Mould, Diane R.
    Chieffo, Carla
    Jorkasky, Diane K.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, : 667 - 676
  • [43] Pharmacodynamic effects of single oral doses of omapatrilat (40 and 80 mg) and fosinopril (20 mg) during salt depletion and salt repletion in normotensive subjects
    Lamarre-Cliche, M
    Bissery, A
    Labatide-Alanor, A
    Ménard, J
    Michel, A
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 121A - 121A
  • [44] Pharmacodynamic effects of single oral doses of omapatrilat (40 and 80 mg) and fosinopril (20 mg) during salt depletion and salt repletion in normotensive subjects
    Lamarre-Cliche, M
    Bissery, A
    Labatide-Alanore, A
    Menard, J
    Azizi, M
    JOURNAL OF HYPERTENSION, 2002, 20 : S44 - S45
  • [45] Pharmacodynamic effects of repinotan on pupil reaction in healthy subjects
    Büttcher, MF
    Heinig, R
    Wensing, G
    STROKE, 2004, 35 (06) : E285 - E285
  • [46] Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects
    Babadjanova, G
    Allolio, B
    Vollmer, M
    Reincke, M
    Schulte, HM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (01) : 53 - 57
  • [47] Chronopharmacology of nebicapone in healthy subjects.
    Almeida, Luis
    Nunes, Teresa
    Loureiro, Ana I.
    Fernandes-Lopes, Carlos
    Torrao, Leonel
    Maia, Joana
    Soares, Eva
    Falcao, Amilcar
    Vaz-da-Silva, Manuel
    Wright, Lyndon
    Soares-da-Silva, Patricio
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1077 - 1077
  • [48] Comparison of the pharmacokinetic and pharmacodynamic properties of S-amlodipine and amlodipine racemate in healthy male subjects.
    Kim, M. G.
    Kim, J. R.
    Lim, K. S.
    Kim, J. W.
    Kim, B. H.
    Chung, Y. J.
    Kim, T. E.
    Yu, K. S.
    Shin, S. G.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S114 - S114
  • [49] Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss
    Dinges, DF
    Arora, S
    Darwish, M
    Niebler, GE
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (01) : 159 - 167
  • [50] Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects
    Liao, WC
    Vesterqvist, O
    Delaney, C
    Jemal, M
    Ferreira, I
    Ford, N
    Swanson, B
    Uderman, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 395 - 406
12345